Physiomics (LON:PYC) Shares Down 18% – Here’s Why

Physiomics Plc (LON:PYC)’s stock price traded down 18% during mid-day trading on Wednesday . The stock traded as low as GBX 0.82 ($0.01) and last traded at GBX 0.82 ($0.01). 13,301,388 shares were traded during mid-day trading, an increase of 45% from the average session volume of 9,156,911 shares. The stock had previously closed at GBX 1 ($0.01).

Physiomics Stock Up 0.8 %

The firm has a market cap of £1.79 million, a price-to-earnings ratio of -13.83 and a beta of 1.69. The business has a 50 day moving average of GBX 0.74 and a 200 day moving average of GBX 0.71.

Insiders Place Their Bets

In other Physiomics news, insider Peter Sargent purchased 459,090 shares of the business’s stock in a transaction on Thursday, November 7th. The stock was bought at an average cost of GBX 1 ($0.01) per share, for a total transaction of £4,590.90 ($5,617.15). 4.18% of the stock is owned by corporate insiders.

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.